Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul;142(7):1509-20.
doi: 10.1007/s00432-015-2090-3. Epub 2015 Dec 11.

Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer

Maria Luisa Gasparri  1   2 , Giovanni Grandi  3 , Daniele Bolla  2 , Beat Gloor  4 , Sara Imboden  2 , Pierluigi Benedetti Panici  1 , Michael D Mueller  2 , Andrea Papadia  5
Affiliations
Review

Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer

Maria Luisa Gasparri et al. J Cancer Res Clin Oncol. 2016 Jul.

Abstract

Purpose: Surgical cytoreduction remains a cornerstone in the management of patients with advanced and recurrent epithelial ovarian cancer. Parenchymal liver metastases determine stage VI disease and are commonly considered a major limit in the achievement of an optimal cytoreduction. The purpose of this manuscript was to discuss the rationale of liver resection and the morbidity related to this procedure in advanced and recurrent ovarian cancer.

Methods: A search of the National Library of Medicine's MEDLINE/PubMed database until March 2015 was performed using the keywords: "ovarian cancer," "hepatic," "liver," and "metastases."

Results: In patients with liver metastases, hepatic resection is associated with a similar prognosis as stage IIIC patients. The length of the disease-free interval between primary diagnosis and occurrence of liver metastases, as well as residual disease after resection, is the most important prognostic factors. In addition, the number of liver lesions, resection margins, and the gynecologic oncology group performance status seem to play also an important role in determining outcome.

Conclusions: In properly selected patients, liver resections at the time of cytoreduction increase rates of optimal cytoreduction and improve survival in advanced-stage and recurrent ovarian cancer patients.

Keywords: Cytoreduction; Debulking surgery; Hepatectomy; Liver metastases; Ovarian cancer; Recurrent ovarian cancer.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest.

References

    1. Abood G, Bowen M, Potkul R, Aranha G, Shoup M (2008) Hepatic resection for recurrent metastatic ovarian cancer. Am J Surg 195:370–373 - PubMed
    1. Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S, Delvart V, Azoulay D, Bismuth H, Castaing D (2006a) Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244:897–907 - PMC - PubMed
    1. Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M, Jaeck D, Saric J, Le Treut YP, Belghiti J, Mantion G, Mentha G, Association Française de Chirurgie (2006b) Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 244:524–535 - PMC - PubMed
    1. Aletti GD, Podratz KC, Jones MB, Cliby WA (2006) Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer—a preliminary report. J Am Coll Surg 203:521–526 - PubMed
    1. Alseidi A, Helton WS, Espat NJ (2006) Does the literature support an indication for hepatic metastasectomy other than for colorectal primary? J Gastrointest Surg 10(1):99–104 - PubMed